公司概覽
業務類別 Household & Personal Products
業務概覽 Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, includingTylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
公司地址 1 Kenvue Way, Summit, NJ, USA, 07901
電話號碼 +1 908 874-1200
傳真號碼 --
公司網頁 https://www.kenvue.com
員工數量 22000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Heather Howlett Chief Accounting Officer -- 15/04/2026
Mr. Russell Dyer Chief Corporate Affairs Officer -- 08/04/2026
Dr. Caroline Tillett, PhD Chief Scientific Officer -- 08/04/2026
Mr. Jonathan Halvorson Chief Digital and Marketing Officer -- 08/04/2026
Ms. Meredith Stevens Chief Operations Officer -- 08/04/2026
Mr. Matthew Orlando General Counsel 美元 647.50K 08/04/2026
Ms. Luani Alvarado Chief People Officer -- 08/04/2026
Mr. Michael Wondrasch Chief Technology and Data Officer 美元 187.98K 08/04/2026
Mr. Leonardo Curado Group President, Latin America -- 08/04/2026
Mr. Carlos De Jesus Group President, North America -- 08/04/2026
Mr. Carlton Lawson Group President, Europe, Middle East and Africa and Latin America 美元 774.18K 08/04/2026
Mr. Amit Banati Chief Financial Officer 美元 553.85K 15/04/2026
Mr. Kirk L. Perry Chief Executive Officer and Director 美元 566.35K 08/04/2026
Mr. Anindya Dasgupta Group President, Asia Pacific -- 08/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Vasant M. Prabhu Independent Director 08/04/2026
Mr. Michael E. Sneed Independent Director 08/04/2026
Ms. Erica L. Mann Independent Director 08/04/2026
Mr. Jeffrey C. Smith Independent Director 08/04/2026
Ms. Sarah Hofstetter Independent Director 08/04/2026
Ms. Seemantini Godbole Independent Director 08/04/2026
Ms. Betsy D. Holden Independent Director 08/04/2026
Mr. Kirk L. Perry Chief Executive Officer and Director 08/04/2026
Ms. Kathleen M. Pawlus Independent Director 08/04/2026
Mr. Richard E. Allison, Jr Independent Director 08/04/2026
Ms. Melanie L. Healey Independent Director 08/04/2026
Mr. Larry J. Merlo Chairman of the Board 08/04/2026
 
所屬ETF (更新日期: 02/05/2026 02:48)
代號 名稱 佔比% 持有日期
SPXVProShares S&P 500® ex-Health Care0.0001%29/04/2026
TSICTruth Social American Icons ETF0.0001%29/04/2026
USRDThemes US R&D Champions ETF0.0001%29/04/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%29/04/2026
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF0.0001%27/04/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.0001%29/04/2026
SPYHNEOS S&P 500 Hedged Equity Income ETF0.0001%29/04/2026
GOFGuggenheim Strategic Opp Fund0.00005%30/11/2025
TOPCiShares S&P 500 3% Capped ETF0.00005%29/04/2026
JUSAJPMorgan ActiveBuilders US Lg Cp Eq ETF0.00005%31/08/2023
AAUAAlpha Architect US Equity 3 ETF0.00004%10/04/2026
MCDSJPMorgan Fundamental Data Sci Md Cor ETF0.00004%29/04/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.00004%29/04/2026
NTSDWisdomTree Efficient U.S. Pls Intl Eq Fd0.00003%29/04/2026
SQSSapient Quality Select ETF0.00003%17/04/2026
WRNDNYLI Global Equity R&D Leaders ETF0.00003%29/04/2026
TACUT. Rowe Price Active Core U.S. Eq ETF0.00002%29/04/2026
BRESBurney U.S. Equity Select ETF0.00002%29/04/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.00001%29/04/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00001%28/04/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13    14    15    16    17  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.